About us Pricing ContactSubscribe

N

Norman Wolmark

Genomic Health (United States)ORCID https://orcid.org/0000-0001-7156-1110

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

New England Journal of Medicine20046,318 citations

Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

New England Journal of Medicine20026,156 citations

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

JNCI Journal of the National Cancer Institute19985,500 citations

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Journal of Clinical Oncology20062,562 citations

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Journal of Clinical Oncology19982,181 citations

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

The Lancet Oncology20101,892 citations

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

JNCI Journal of the National Cancer Institute20051,331 citations

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum

Diseases of the Colon & Rectum1997362 citations